Hormonal
Tirzepatide produces significantly greater long-term total body weight loss and fat mass reduction compared to Semaglutide in real-world clinical practice, with effects becoming distinct after 6 months.
If you are choosing between Semaglutide and Tirzepatide for long-term weight management, Tirzepatide offers significantly greater weight loss after 12 months. To maximize results and protect your muscle, you must combine the medication with a program that includes strength training twice a week and a protein intake of 60-90 grams daily.
At 6 months, weight loss was similar ((cid:0) 9.09 % vs (cid:0) 10.7 %), but by 12 months, Tirzepatide achieved greater reduction (22.02 % vs 11.59 %).
Why this rating
Real-world observational study with a large sample size (N=269) but lacking a control group and randomization.
Source
Real-world effects of incretin-based Obesity medications on body composition
Rahila Bhatti et al. · Obesity Pillars · 2025
DOI 10.1016/j.obpill.2025.100229
More from this paper
- Females experience significantly greater weight loss than males when treated with incretin-based obesity medications (Semaglutide and Tirzepatide).Moderate
- Skeletal muscle mass can be preserved during significant weight loss induced by incretin-based medications if the patient adheres to a program involving twice-weekly strength training and adequate protein intake (60-90 g/day).Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →